Patients

Five things for pharma marketers to know: Wednesday, October 18, 2017

Five things for pharma marketers to know: Wednesday, October 18, 2017

By

More than half of doctors say patients make critical, racist, or sexist comments; Anthem to launch its own PBM; drugmakers face criticism for waste

Five things for pharma marketers to know: Tuesday, October 10, 2017

Five things for pharma marketers to know: Tuesday, October 10, 2017

By

Patients complain about positive healthcare ads; some drugmakers skirt Open Payment rules; new law requires disclosure of drug price hikes in California

Online patient communities consider the platform: Facebook, or somewhere more private?

Online patient communities consider the platform: Facebook, or somewhere more private?

By

Facebook itself has more than six million health-related groups.

American Cancer Society: 'We are more than just a research organization'

American Cancer Society: 'We are more than just a research organization'

By

The new brand campaign, Attacking Cancer from Every Angle, showcases all the services the organization provides.

Five things for pharma marketers to know: Friday, September 1, 2017

Five things for pharma marketers to know: Friday, September 1, 2017

By

600 patients are eligible for CAR-T therapy; the FDA halts Keytruda combo study for multiple myeloma; the regulator delays decision on Herceptin biosimilar

Infographic | What patients want: a better healthcare experience

Infographic | What patients want: a better healthcare experience

By

Patients are demanding more of their healthcare experience — and that includes from their healthcare providers, according to two new surveys.

4 Ways Marketers Can Work With Advocacy Groups to Achieve Brand Objectives

4 Ways Marketers Can Work With Advocacy Groups to Achieve Brand Objectives

As the influence of patient communities and advocacy groups grows, how can marketers work these organizations to achieve brand objectives?

Drugmakers turn to tech to better demonstrate empathy

Drugmakers turn to tech to better demonstrate empathy

By

Frustrated by its inability to empathize with patients, pharma has turned to tech to teach providers and caregivers what illness really feels like.

Why Science Needs a Story

Why Science Needs a Story

If scientific storytelling alone can impact health outcomes, then how can we apply that knowledge in practice?

Want to Win Hispanic Patients? Get Personal

Want to Win Hispanic Patients? Get Personal

More than other patient groups, they want a deeper, ongoing relationship with caregivers.

Five things for pharma marketers to know: Monday, July 17, 2017

Five things for pharma marketers to know: Monday, July 17, 2017

By

More Americans are reporting medication errors; Public Citizen urges lawmakers to oppose off-label bills; BMS launches new I-O campaign

Half of clinical-trial sites offer free transportation to patients

Half of clinical-trial sites offer free transportation to patients

By

Consent forms and reimbursement are the main deterrents of offering the service.

How should pharma market to millennials?

How should pharma market to millennials?

By

The opportunity to reach the millennial audience is great, and there's a lot that brands can do now to ensure that companies stay relevant to Gen Y cultural trends.

5 Ways to Engage in Powerful Storytelling, in a Fragmented Media Environment

5 Ways to Engage in Powerful Storytelling, in a Fragmented Media Environment

Too often marketers get caught up in their own company, brand, or workforce as the hero of their own story.

Roundtable: Social centricity in oncology

Roundtable: Social centricity in oncology

By

Industry leaders discussed why a social-centric approach is especially important in oncology, particularly as it relates to health systems, interactions with healthcare providers, and family support.

Outcome Health raises $500 million in financing round

Outcome Health raises $500 million in financing round

By

The deal highlights ongoing interest in the influential point-of-care market.

Five things for pharma marketers to know: Friday, May 26, 2017

Five things for pharma marketers to know: Friday, May 26, 2017

By

FDA presents ideas to tackle drug prices; patients aware of side effects more likely to report them; scientists use Apple's Research Kit for clinical purposes

Apple helps a blind drummer and nonverbal teen thrive in new spots

Apple helps a blind drummer and nonverbal teen thrive in new spots

Siri and accessibility features take center stage in ads for Global Accessibility Awareness Day.

Expert Q&A: Getting patient centricity right

Expert Q&A: Getting patient centricity right

Five sector pros discuss adapting to patient-centricity and how pinpointing patient needs leads to success.

Five things for pharma marketers to know: Thursday, May 18, 2017

Five things for pharma marketers to know: Thursday, May 18, 2017

By

Docs spend little time telling patients about cancer costs; Shire to file hereditary angioedema drug with the FDA by 2018; Philips CEO on access obstacles

Infographic: The battle for medication adherence

Infographic: The battle for medication adherence

Drugmakers and providers alike struggle to find the best tools, words, and technologies that will improve adherence rates among patients with chronic diseases.

Five things for pharma marketers to know: Monday, May 15, 2017

Five things for pharma marketers to know: Monday, May 15, 2017

By

Funding for patient-assistance charities makes up 7% of operating expenses for drugmakers; Avanir ad under fire; Trump to consider Medicare rebates

Day 1 at Health Datapalooza

Day 1 at Health Datapalooza

By

HHS Secretary Tom Price calls for health IT that works for clinicians and better interoperability.

5 of healthcare's hardest nuts to crack

5 of healthcare's hardest nuts to crack

How are pharma, clinical, and startup execs addressing some of the biggest challenges facing their businesses today?

Dr. John Brownstein, Circulation

Dr. John Brownstein, Circulation

Dr. John Brownstein is cofounder of Circulation and chief innovation officer at Boston Children's Hospital.

Jeff Ceitlin, HVH Patient Precision Analytics

Jeff Ceitlin, HVH Patient Precision Analytics

Jeff Ceitlin is CCO of HVH Patient Precision Analytics.

Adrian Aoun, Forward

Adrian Aoun, Forward

Adrian Aoun is the CEO and founder of Forward.

Nothing Will Replace Human Doctors, Not Even Robots

Nothing Will Replace Human Doctors, Not Even Robots

Healthcare is one industry that hangs in this delicate balance, in large part due to the fact that it necessitates a blend of science and empathy.

What doctors have to say about those DTC ads

What doctors have to say about those DTC ads

By

We had SERMO, a social network for physicians, ask about 1,700 physicians what they have to say about the impact of DTC on patient care and choices. Note: It's not pretty.

Five things for pharma marketers to know: Wednesday, March 22, 2017

Five things for pharma marketers to know: Wednesday, March 22, 2017

By

Novartis' heart-failure drug fails in clinical trial; Sanofi, Regeneron file Dupixent patent suit; FDA approves Newron's Xadago for PD